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Abstract
Background: The United Kingdom is experiencing an increase in drug-related deaths and serious bacterial
infections among its most vulnerable citizens. Cuts to essential services, coupled with a growing homeless
population, create a challenging environment to tackle this public health crisis. In this paper, we highlight an
underexplored environmental constraint faced by people living and injecting drugs on the streets. Access to water
for injection is restricted in the UK, due to legislative and financial barriers. Austerity measures, such as public toilet
closures, further restrict the ability of people made homeless to access clean water and protect themselves from
health harms.
Methods: We generated questionnaire (n = 455) and in-depth qualitative interview (n = 32) data with people who
inject drugs in London for the Care and Prevent study. Participants provided detail on their life history; drug use,
injecting and living environments; health conditions and care seeking practices.
Findings: A high proportion of the survey sample reported lifetime history of street homelessness (78%), bacterial
infections (65%) and related hospitalisation (30%). Qualitative accounts highlight unsafe, potentially dangerous,
injection practices in semi-public spaces. Multiple constraints to sourcing sterile water for injection preparation were
reported. Alternatives to sterile water included puddle water, toilet cistern water, whisky, cola soda and saliva.
Participants who injected heroin and crack cocaine together unanimously reported adding water at two stages
during injection preparation: first, adding water as a vehicle for heroin (which was then heated); second, adding
cold water to the heroin mixture prior to adding the crack cocaine. This new finding of a stage addition of solvent
may represent an additional risk of infection.
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Conclusion: Currently, harm reduction equipment and resources for safe injecting are not meeting the needs of
people who inject drugs who are street homeless or unstably housed. Preparation of injections with non-sterile
water sources could precipitate bacterial and fungal infections, particularly when used without the application of
heat. It is crucial that water for injection, also skin cleaning, is made available for the unstably housed and that
harm reduction messaging is tailored to speak to the everyday realities of people who prepare and inject drugs in
public spaces.
Keywords: Water for injection, Injection preparation, People who inject drugs, Homelessness, Skin and soft tissue
infections, Crack cocaine, heroin
Background
Health harms are increasing among the estimated 200,000
people who inject drugs (PWID) in the United Kingdom
(UK). Since 2012, there has been a steady increase in hospita-
lisations for serious bacterial infections [1], a doubling of
opioid-related deaths [2], and outbreaks of invasive and in-
fectious diseases among PWID, particularly among those
who are homeless [1–3]. The recent outbreak of coronavirus
(COVID-19) is of particular concern, given vulnerability to
respiratory problems among PWID in the UK, many of
whom also smoke (crack cocaine, heroin, tobacco) and have
a much higher incidence of chronic obstructive pulmonary
disease (COPD) than the general population [4]. Drug-
related deaths in the UK are higher than any European
Union (EU) country; in the year before Britians exit they
accounted for one third of all reported in the EU country
and, in the year prior to Britain’s exit, accounted for a third
of all reported in the EU [5]. In an austerity context, where
health harms are exacerbated by cuts to social and health
services [6]—particularly among a growing homeless popula-
tion [7]—services must innovate to reach those most at risk.
To do so effectively, it is essential that interventions are in-
formed by an in-depth understanding of current constraints
to safe injecting practices and how environments can be
modified to facilitate or protect against health harms.
Homelessness and public injecting are interrelated and
constitute part of the structural risk environment fostering
health harms, such as bacterial and viral infections, among
PWID [8]. Skin and soft tissue infections (SSTI), such as
abscesses and cellulitis, are a growing cause of hospitalisa-
tion among PWID [9], with homeless PWID particularly
susceptible to SSTI and related complications, such as
septicaemia and endocarditis [10]. This increased risk
among the unstably housed may be a consequence of in-
ability to maintain safe and hygienic injection practices
when injecting in public places, where injections may be
hurried, with a lack of clean surfaces, poor lighting and
difficulties in accessing clean water to use as a drug solv-
ent [11–15]. The use of water from toilets, cisterns,
ditches and puddles has been noted [11, 15–23], and these
sources are likely to be contaminated with particulates
and microorganisms. Although few studies have
specifically explored the role of water used to prepare in-
jections in relation to SSTI among PWID, there are indi-
cations that the use of puddle and toilet water is a risk [20,
21]. Indications of difficulty accessing water among the
most marginalised are of crucial concern also, given the
potentially protective benefit hand washing can have
against viral infections such as influenza and COVID-19.
Water is required to prepare street drugs such as her-
oin and crack cocaine into a solution for injection. As a
component of injection preparation, water is a concern
due to its ability to carry micro-organisms, and as it
might be shared when groups of people inject drugs to-
gether. In the UK, “water for injection” (WFI) is a sterile
pharmaceutical product used to reconstitute medicinal
injections. It has to meet a range of quality standards in-
cluding limits on particulate contamination and bacterial
endotoxins [24]. Prior to 2003, supply of WFI to PWID
was prohibited in the UK under the 1971 Misuse of
Drugs Act. In response to the increased evidence of
hepatitis C (HCV) risk from sharing injecting parapher-
nalia (i.e. injecting equipment other than needles and sy-
ringes) [25, 26], section 9A of the Act was amended in
2003 to decriminalise the supply of WFI and other para-
phernalia by practitioners, pharmacists and people en-
gaged in the “lawful provision of drug treatment
services” [27]. Under the Medicines Act 1968, however,
all medicines for parenteral administration, including
WFI, are classified as a prescription only medicine [28].
This prevented needle and syringe programmes (NSP)
effectively supplying WFI, despite the 2003 law change,
unless it was issued under prescription. Contraventions
to the law during this time included the supply, by a so-
cial enterprise, of plastic 1.4 ml sterile water ampoules.
Available from September 2003, supply was halted in
June 2004 by the Medicines and Healthcare Regulatory
Authority (MHRA), as the ampoules were deemed by
the MHRA “to have the appearance of a medicine”, and
thus illegal to distribute without a medicines license
[29]. A campaign ensued to change the status of WFI
from prescription only medicine to enable its supply
though NSP. In June 2005, this was realised; with the
regulations amended so that drug treatment services
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(including NSP) could supply WFI to PWID [30]. The
status of WFI as a prescription only medicine remains
however, with a prescription required for all other uses
other than supply to PWID.
A maximum 2ml volume restriction was initially
placed on ampoules of WFI supplied to PWID, in
order to reduce potential for water sharing [28]. This
concern was largely related to HCV risk, given evi-
dence that HCV can survive for up to 3 weeks in bot-
tled water and on water containers after use [25].
There was a further amendment of the Medicines Act
in 2012 to allow the supply of 5 ml water ampoules
by drug workers to PWID, but with no public an-
nouncement to this effect, awareness of the change
among injecting equipment manufacturers and pro-
viders was minimal [31]. The only 2 ml licensed and
marketed WFI available in the UK is in a glass am-
poule. A “safe snap” ampoule snapper was made
available in 2006 [23, 29] to reduce the risk of glass
cuts and associated HCV transmission potential. Some
NSP remained reluctant to provide glass ampoules
due to concerns about ampoule cost or the percieved
potential for glass cuts if opened without an ampoule
snapper [23]. Distribution of 5 ml ampoules of water
is limited again due to cost, and also ignorance of the
change in the law, drug litter potential, and fears of
HCV infection through shared ampoules. At present,
in the UK, provision of WFI through NSP is limited,
fragmented and inconsistent. The majority of injecting
supplies are now accessed through community phar-
macies, which usually dispense standard issue inject-
ing packs, and these rarely contain WFI.
There is a need to interrogate current harm reduction
messaging and injecting paraphernalia provision to as-
certain whether it meets the needs of PWID who are
rough sleeping or unstably housed. In the UK, this is a
growing population, increasingly vulnerable to health
harms. Relatively little research has focused on the use
of water for illicit drug preparations, apart from asses-
sing viral transmission risk. Current harm reduction ad-
vice advocates the use of WFI, with the “next best”
alternative boiled and cooled potable (drinkable cold
tap) water, and after this, cold tap water. Our research il-
lustrates that while these hierarchies of best practice
may be actionable by people living and injecting in
homes, they are not necessarily feasible for people living
or injecting on the streets. We present mixed-method
data generated with PWID in London to highlight the
environmental constraints faced by people living and
injecting drugs on the streets, with a focus here on re-
ports of liquids used for drug preparation purposes. In
doing so, we aim to inform pragmatic interventions to
reduce drug, and other related, health harms among the
most marginalised PWID in the UK.
Methods
This paper reports on data from the London-based, Na-
tional Institute for Health Research funded, Care and
Prevent Study. This mixed method study generated
questionnaire with urinalysis (n = 455) and qualitative
interview (n = 32) data with PWID in London, UK, be-
tween October 2017 and March 2019. The aim of Care
& Prevent is twofold: (1) to explore associations between
SSTI and the renal disease, AA amyloidosis, including
though risk screening and specialist referral and (2) to
explore the risk factors and contexts related to SSTI
among PWID. This paper will present findings pertain-
ing to the latter aim, primarily drawing on qualitative ac-
counts of injection preparation practices.
Study methods have been published in detail [32]. Par-
ticipants were recruited through word of mouth and re-
cruitment flyers at drug treatment services, homeless
hostels and day centres across London. Eligibility criteria
comprised the following: ability to provide informed con-
sent, aged 18 years or over and having a history of psycho-
active injecting drug use. Surveys, urinalysis and
qualitative interviews primarily took place at private
rooms in the recruiting services, with some qualitative in-
terviews conducted in a café, on the street or in partici-
pants’ homes. All were reimbursed a £10 voucher for the
survey and urinalysis and £20 for an interview. The ques-
tionnaire was entered into Open Data Kit (ODK) software
and researcher administered using the ODK Collect appli-
cation on Android tablets [33]. Participants provided in-
formation on their socio-demographics, drug use history,
injection preparation and administration practices, equip-
ment use and reuse, health care practices, lifetime experi-
ence of SSTI and other health conditions. Qualitative
interviews sought detail on areas outlined above, were of
60–120min duration, audio-recorded with consent and
professionally transcribed verbatim.
Using Stata version 15.1, the characteristics of study
population were described using numbers and percentages
for categorical variables, means (standard deviations) for
normally distributed continuous variables and median
(95% CI) for non-normally distributed continuous vari-
ables. No multivariate analyses were undertaken for
this paper as the risk variable, water, was not mea-
sured. Qualitative analysis was informed by construct-
ivist grounded theory methods [34] with data
analysed as generated in order to inform the direction
of subsequent interviews, coding, case selection,
memo and theory generation. A selection of inter-
views was open coded using process or gerund codes
[34]. Consolidation of these codes formed the basis of
a coding frame, against which all transcripts were
coded (first stage). Second stage coding comprised in-
ductive open coding of data in each category to
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inform theme development and interpretation for
publication.
Ethical approval was granted by the London School of
Hygiene and Tropical Medicine Observational Research
Ethics Committee [12021], the London Bridge Research
Ethics Committee and Health Research Authority [17/
LO/0872]. All participants provided written consent
after receiving study information and assurance of
confidentiality.
Results
Survey
Three quarters of those participating the survey (75%,
341/455) identified as male and (74%, n = 336) as white
or white British. Participants’ mean age was 46 years
(range 21 to 68). Most (79%, n = 360) were currently re-
ceiving opioid agonist therapy, with two thirds (62%, n =
284) reporting drug injecting in the past 12 months. Use
of crack and heroin in combination, aka “snowball”, was
favoured, with 49% (n = 255) reporting this as their pri-
mary drug injected, risng to 58% among those who had
injected in the past year (n = 164/284). Of note, given
the vulnerability to COVID-19 among those with re-
spiratory problems, 61% (n = 278) of the sample re-
ported current crack smoking, 47% (n = 214) current
heroin smoking, and 91% (n = 414) current tobacco
smoking, the latter for a median duration of 29 years.
Sixty-four (14%) participants had received a diagnosis of
COPD, with a number likely undiagnosed. Most partici-
pants (78%, n = 355) reported a lifetime history of street
homelessness with a mean duration of four years (range
< 1 to 30 years). Just over half (57%, n = 259) were un-
stably housed for all or most of the past 12 months, with
33% (n = 152) in hostels, 14% (n = 61) street homeless,
7% (n = 31) staying with friends or family and 3% (n =
15) in prison. Participants were asked about lifetime ex-
perience of abscesses, cellulitis, venous ulcers and ven-
ous disease. The majority (65%, n = 296) had
experienced at least one of these conditions, of whom
46% (n = 137) reported consequential hospitalisation.
Notably, of the 291 participants (64%) reporting a bac-
terial infection (abscess or cellulitis), 27% (n = 80) re-
ported a diagnosis of septicaemia and 7% (n = 21)
endocarditis.
Qualitative findings
Qualitative interview participants (n = 32) had similar
characteristics to the survey sample, with 69% (n = 22)
male; 81% (n = 26) white or white British, average age of
43 years old and 94% (n = 30) had experienced home-
lessness. Qualitative accounts indicate how injecting
preparation practices, and the environments in which
they are situated, can facilitate risk for SSTI and serious
sequelae. Below, we present data pertaining to the injec-
tion preparation process with a focus on water source as
an environmental constraint to safe practice and the
strategies employed by participants to navigate this
constraint.
“Snowball” injection preparation requires “cooler”
Participants were asked to describe in detail their
process for preparing a “typical injection”. All partici-
pants followed a similar procedure for preparing heroin,
with variation in relation to amount of acidifier used and
the order in which acidifier, heroin and a solvent were
combined in the spoon (for more information on this
process, see [35]). This mixture was then heated, prior
to drawing up through a filter ready for injection. Those
who injected heroin and crack cocaine in combination
all referred to the addition of cold water (or other cold
solvent) prior to adding the crack. The proportion of
cold water or “cooler” added to the heroin mix was de-
tailed precisely and appeared remarkably uniform across
accounts. Troy and Tim’s accounts are indicative:
The citric goes into the spoon first, I always inject
probably 100mls1 of water, or like suck in 100mls
water … I just put the brown in and cook up the
brown, put 80mils of water in, then 20mils of cooler
and then the crack, squash it up and use a filter.
So, you don’t heat the crack do you?
No, I heat the brown and then I put a cooler in.
Yeah, like 20mils of water, yeah. (Troy)
Yeah, put the gear in, burn it up, cook it up … put
water in and then put citric in … and cook, burn
the brown up, then put about 20mil cooler and then
put the white in, and just crush the white up, and
draw it up and bang it. (Tim)
While Ross and Lee do not specify the amount of
cooler used, or refer to it in those terms, their method
follows a similar process:
I’d put a little bit of citric in the spoon, open the
stuff [heroin], put it in, add the water, cook it, put it
down, add the rest of the water, put the white
[crack] in, crush it up properly, put the filter in, pull
it up. (Lee)
I would put in two bags of heroin, so maybe like .4
[unit of street drug deal] and I’d then put in .2 of
1The participant’s reference to ‘mls’ is to the unit grading on an insulin
syringe, with 100 units equivalent to 1ml.
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crack. No, first I would put in .4 of heroin, maybe 1
citric [sachet] for £20 worth of heroin, I would cook
that up, I’d then add a little bit of cold water and
put £10 worth of crack in there, make sure I can’t
see it anymore, although it’s hard because it’s quite
shit and then I’d suck it up, usually using the 2 ml
[syringe]. (Ross)
Ross’ reference to “quite shit” is echoed by others inter-
viewed, with a general perspective that the quality of the
crack available through London street markets at the time
of the study was poor. When the end-point of preparation
was judged by clarity of the injection solution, this could re-
sult in the addition of excessive acidifier to break down cut-
ting agents and manufacturing by-products in the crack
[35]. What these accounts also highlight, however, is that a
proportion of the drug injection solution has not been sub-
jected to heat, with implications for health harms depend-
ing on the contamination present in the “water” sourced.
Desperate constraints: sourcing water alternatives
The environments in which participants prepared injec-
tions posed multiple constraints to enacting “best prac-
tice” harm reduction advice. As noted above, nearly 80%
of the survey sample reported a lifetime history of rough
sleeping, rising to 94% of those providing qualitative ac-
counts. Many interview participants spoke of their “typical
injection” preparation processes occurring in public or
semi-public settings such as public toilets, bin sheds, stair-
wells, car parks, parked cars and even moving buses. As
detailed in other qualitative studies [11, 13–15], semi-
public injecting is characterised by opportunity, urgency
and constraint. Ben refers to the need for haste when
injecting in semi-public settings “because you’re scared
the police are going to come, or someone’s going to
come”. When asked how this can impact on the injection
preparation practice he replies “people might forget to put
citric in or use puddle water”. While he is fearful to do this
himself, he has seen others use puddle water “a lot”.
When asking about injection preparation practices, the
first author took care to elicit specific detail about type
and amount of acidifier used, but did not think to lend
the same scrutiny to water source and type. Unelicited
accounts of solvents used in the preparation process un-
settled this lack of attention. Jeff, for example, spoke at
length about the embodied effects of using cola as a
water alternative, of which this quote is an extract:
I wouldn’t care where I cooked up, I’d cook up on
rain water off the cars, car bonnets. I’ve even cooked
up on Coca-Cola. Coca-Cola, yeah, and when you
inject it you can taste it more, you can feel the coke
going down the back of your throat, you feel like
you’ve had a sip of coke. (Jeff)
Dean spoke of injections that “sting like fuck” when
using “neat lemon juice” in place of water, acknowledg-
ing that he was “destroying my veins” by doing so. The
use of alcohol in place of water was also frequently men-
tioned, and given that many rough sleeping participants
were also heavy drinkers, this was likely to be a readily
accessible liquid for injection preparation on the street:
I’ve used whisky, Tennent’s Super Lager, all sorts to
do my hit … vodka, whisky, you name it, I’ve used
alcohol to do my cooking, to do my [hit] (Neil)
These practices were not spoken of lightly. The need
to source an alternative to water was a desperate con-
straint in the context of injection preparation. As Alex
indicates: “I’ve used alcohol or fucking, yeah, man, you
do things when you’re desperate, you know.”
The expression of desperation was most acute when
participants spoke of using saliva as an alternative to
water. For those who did so, this was framed as a last
resort:
I was that desperate one time I was even trying to
cook up with my own spit, that’s how desperate I
was. [Did it work?] No, it was fucked, it wouldn’t
cook, just frazzled … I was going to try it but when
I seen it’s frazzled I said fuck it and I flung it away
(Jeff)
Jeff was lucky. Although he lost the hit he had been
hoping for, he did not experience the health harms
recounted by Dev in conversation with the first author:
You said you’ve got a wicked scar on your groin,
right?
It’s infection, it got infected. What it was, there was
no water actually and I had to use a bit of saliva. I
had to use a bit of saliva, there was more gear, yeah.
There was no water, so you used saliva?
Yeah, thinking that could work and it didn’t work,
man. It worked, I still got my hit, but I also got the
worst infection of my life, I nearly died … Yeah, I
was in hospital for nearly 3 months. Septicaemia.
Where were you cooking up the hit?
In the flats, bottom of the flats. [In a stairwell?]
Yeah, I was homeless at this time, innit.
Can you tell me about it in detail, like walk me
through what happened?
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What I remember, I must have gone out, graft,
scored, I didn’t have enough fucking [water] … I
didn’t have no trouble getting my groin, I must have
got it and then it, I had some sort of fever like fuck-
ing hell, fever come across me and it was bad so I
had to go to hospital … after that I was knocked out
then woke up in the hospital bed, I went for fucking
surgery. And then a second surgery after that be-
cause they didn’t get all the infection out.
What did they say it was? Like, how did it get
that bad that quickly?
It was an infection, an infection was found, a bug
was found in the mouth … Yeah, in any mouth, in
people’s mouths. Just that bug and it’s a nasty bug, a
right nasty bug. And that’s why I remember when I
tried to put a bit of saliva in, know what I mean, so,
it makes sense.
So, was there was nowhere else you could get
water from, or …?
No, no.
Navigating constraint: trying to stay safe
The context of constraint for many was one where pub-
lic access to water, for drinking, washing or other pur-
poses was not guaranteed. This has implications not
only for injecting related practices but also for the ability
to stay hydrated, as Jeff mentions in passing below:
We were on the streets, I can’t remember where I was,
but there was no water about anywhere and it was a
red-hot day as well, there was no water anywhere. And
I was dehydrating, dehydrating, plus there’s no toilet,
no taps anywhere around, no rain, no nothing. I was
proper sick for a hit, in the end because I couldn’t find
no water and my spit wouldn’t work and then I got an-
other bag and I had to do it with a puddle of water
and then like filter the water through the sterits [alco-
hol swab], filter it out that way.
Through the alcohol swabs?
Yeah, just to get the dirt of the water.
Of note in this excerpt are the lengths that Jeff
went to, not only to have a hit, but to navigate the
constraints of his environment. Filtering puddle water
through an alcohol swab (provided by NSP for wiping
injecting sites) is a poignant example of self-care, also
illustrating the short-sighted limitations of service
provision where swabs are deemed essential but water
ampoules are not. As Sara says “you don’t get water
with the [injecting] kit.”
For Sara, and some other unstably housed participants,
the answer is to carry bottled water. As Troy says: “I
usually have a bottle with me, a bottle of water, yeah”
and Jade: “then I would just draw up some water, be-
cause I have a bottle of water or something”. Ben details
his rationale for using bottled water and his strategy for
obtaining it:
A lot of the time people would use puddle water.
That’s a thing, yeah. But I was always scared of that,
so I always got scared in case there was like an ani-
mal and then you’d suck the animal in and then
you’d put the animal inside yourself … I used to al-
ways get people to buy me bottles of Volvic water
and then I’d pull up from the bottle. People would
come and buy me drinks and food all the time. They
always asked me, what do you want from the shop?
Okay, so like people walking by on the street?
Yeah.
Yeah. So you’d specifically ask for bottled water
so you could use it for having a hit?
Yeah. Yeah-yeah-yeah. (Ben)
Participants also spoke of carrying baby wipes and
swabs with them, particularly useful to wipe hands and
injecting sites in the absence of water to wash with. Neil,
who had prepared injections with a variety of alcoholic
beverages, spoke with pride of keeping his injecting sites
clean on the streets, showing the first author his stash of
alcohol swabs, always replenished in his coat pocket: “I
always have alcohol swabs and wipes and all that, just
wee things like that, I always keep one … I’m just a sur-
vivor, love”. Lee would also carry baby wipes and bottled
water with him when possible. He prioritised finding toi-
lets to inject in that were “clean” and where he could
wash his hands; however, bottled water (or an empty
bottle) was often necessary, given the difficulty of
obtaining water with a syringe from a public access sink
when preparing and administering an injection in a
closed toilet cubicle.
Discussion
A well-established body of literature evidences health
harms and health system burden associated with inject-
ing drug use [36, 37]. UK surveillance data illustrate an
increase in mortality and morbidity among PWID over
the past decade [5, 38] particularly in areas of socio-
economic deprivation [38] and those hit hardest by local
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authority funding cuts [39]. In the decade since the im-
plementation of UK government fiscal austerity policies
(2010–2020), it is estimated that local authorities will
have faced a core funding reduction of £16 billion com-
pared to the preceding decade [40]. These cuts have im-
pacted not only on housing and welfare provision but
access to clean water on the city streets. As the homeless
population has increased in the UK, most notably in
London,2 access to public amenities have decreased, with
673 public toilets closed by major councils since 2010
[42]. At the same time, drug treatment services, facing
sustained budgets cuts of at least 18% [39], have reduced
costs where possible, impacting on the availability of
water provision in NSP equipment packs. The impact of
these structural changes on injecting environments and
practice is reflected in our qualitative accounts, with par-
ticipants describing injection preparation with solvents
ranging from puddle water to whisky to saliva when
injecting in public and semi-public spaces.
The risks or health harms associated with use of alter-
native solvents for injection has not, to date, been eluci-
dated in the literature, apart from reference to bacterial
infections arising from saliva contaminated injections.
While some harms are proven, many are theoretical and
not easily measured. This is particularly the case in rela-
tion to use of alternatives to water. Alcohol for example,
although an antibacterial and effective solvent for base
drugs such as heroin, as an injection solvent may pose
an overdose risk particularly in combination with heroin,
methadone or other sedatives. Although the amount of
alcohol injected is small, when used intravenously, it
does not go through the liver before the brain, as it
would with oral (drinking) administration; therefore, it
reaches the brain faster and in a more concentrated
form. Puddle water may contain a range of organisms
found in the environment, including the heat resistant
spores of anaerobic bacteria including Clostridium spe-
cies that cause tetanus and botulism [43] and Pseudo-
monas species, associated with multidrug resistance and
sepsis [21], as well as particulate matter and environ-
mental chemicals. Saliva is a polymicrobial fluid. While
heating drug solutions containing saliva may inhibit bac-
terial growth, not all organisms are likely to die at the
same temperature, the same solution acidity or in such a
short duration of heating time. Other components of sal-
iva, such as proteins, may prompt an immune response
if injected. The potential for infection from saliva injec-
tions is therefore highlighted as a concern.
Our study is the first to report, to our knowledge, pur-
poseful use of saliva as an alternative to water in injec-
tion preparation. Bacterial infections attributed to saliva-
contaminated injections have been documented in the
literature, however, only in relation to the licking of nee-
dles and/or injection sites. Binswanger et al. [44] found
that of 169 community-recruited PWID in San Fran-
cisco, 28% (n = 46) reported licking their needles prior
to injection. On examination, 32% (n = 54) presented
with abscesses and/or cellulitis. After controlling for
skin-popping and years of injection drug use, participants
who licked their needles were more likely to have an ab-
scess or cellulitis than those who did not. A study of 40
hospitalised PWID in New York found that 33% (n = 13)
reported licking their needles prior to injection with three
also licking their skin prior to injection to clean the site
and 12 afterwards [45]. The majority 68% (n = 27) had
been admitted to hospital for treatment of bacterial infec-
tions although no statistically significant association was
found between needle licking and bacterial infection. Sev-
eral case series and reports have documented infections
(primarily endocarditis, but also femoral abscess) attrib-
uted to oral bacterial (oropharyngeal organisms) among
PWID who report licking their needle and/or injection site
prior to drug injection [46–49].
Of note, is the consistency of detail provided by quali-
tative participants about preparation of heroin and crack
cocaine in combination for injection and that this differs
from the only other study found to illustrate the steps
taken in this process. Ponton and Scott (2004) recreated
typical injection preparation practices with 65 people re-
cruited through three NSP sites in England. Injection
preparation was demonstrated for the following: heroin
(n = 47), crack cocaine (n = 8) and heroin and crack to-
gether (n = 10). In contrast to Ponton and Scott’s find-
ings that crack is added to the heroin mixture after
heating, our participants all describe using cold water
(or water alternative) to cool down the prepared heroin
solution before crack addition. This is undertaken to
prevent the crack cocaine congealing in a high
temperature solution but may also have implications for
bacterial contamination and infection. Heating drug so-
lutions has been indicated to inactivate HIV [50] and
prevent systemic candidal infections [51]. Heroin solu-
tions in the UK are prepared with acid to convert base
heroin to a soluble salt. The excess use of acid is impli-
cated in the causal chain to SSTI by precipitating venous
sclerosis [35, 52]. Heating with acid can, however, also
kill non-spore-forming bacteria, depending on the solu-
tion acidity and temperature reached.
It is difficult to assess bacterial risks associated with
the use of cold water for injection preparation or the use
of alternative water sources, given that most literature
mentioning water in the injection process does so in the
2London is base for 27% of people who are street homeless in England.
This is a growing population, with street counts and estimates placing
1,283 people rough sleeping in London on one Autumn night in 2019,
representing a 13% increase from a comparable night in 2017 [41].
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context of HIV and HCV transmission potential. Ciccar-
one and Bourgois [53] present a hypothesis that cold
water heroin solutions may have fostered HIV transmis-
sion in the early phases of the epidemic in the USA.
More recently, a model of HIV transmission examining
heroin source-type (including cold water prepared solu-
tions) supports this prior hypothesis [54]. Gaskin et al.
[55] present one of the few studies with a HCV transmis-
sion remit to detail water source. Participants comprise 40
NSP clients based in Worcestershire, England. The majority
(70%) reported using one water source only: for 72%, this
was tap water, followed by 21% using boiled and cooled
water. The authors highlight the discrepancy between
participant-reported perceptions of safe (or ideal) practice
and their actual practice. While the majority used tap water
for injection preparation, only 10% considered this to be an
ideally hygienic source. The authors make a strong recom-
mendation for provision of sterile water for injection, in
order to “meet the basic needs of individuals and help facili-
tate behavioural change” [55:429]. They report that, subse-
quent to their study, the Worcestershire Community Drug
Team commenced the low-threshold provision of sterile
water in ampoules.
Ponton and Scott (2004), also recruiting PWID
through NSP in England, include information on water
source. Of the 57 participants demonstrating heroin
preparation, with or without crack cocaine, 61% (n = 35)
used tap water, with other sources including bottled
water (18%, n = 10), boiled water (11%, n = 6) and sterile
water from ampoules (2%, n = 1). The only group docu-
mented not to heat their solution were people preparing
crack on its own, with three using tap water, one using
“boiled and cooled” water from the kettle, one using bot-
tled water and one using water obtained from a toilet.
Despite the latter finding, no reflection is included on
the bacterial or other health implications of this practice.
Interventions may be feasible in reducing risk. Campbell
[23] reports on the pilot provision of 2 ml plastic water
ampoules to PWID in Glasgow over 2 months in 2012.
Prior to the pilot, only three of 74 NSP services provided
WFI, and this was in glass ampoule form. The plastic
ampoules were supplied separately to the injecting
packs, with PWID invited to take as many as they
needed. Over the 2 months, at the three pilot sites, 31,
518 ampoules were distributed, with footfall at the sites
increasing by 25% during this period compared to the
preceding 2 months. Sites not providing water experi-
enced a 5% decrease. Of 42 clients interviewed during
this time, four (9%) identified using toilet water (from
the bowl) or puddle water prior to the pilot—with none
reporting use of these sources during the intervention.
Concerns around the potential for HCV transmission
through sharing of water among PWID led to the legal
framework for UK supply described in the introduction.
Given the reluctance to provide glass ampules by some
local authorities, it is timely to revisit this evidence and
associated guidance. Heimer and colleagues [56] report
recent laboratory studies illustrating that HCV transmis-
sion occurs via the needles and syringes used in prepar-
ing and injecting drugs, not through shared
paraphernalia. They recommend, given these results,
that NSP “may want to reconsider expanding scarce re-
sources to provide supplies that will do little or nothing
to prevent HCV transmission” [56:471]. This view sur-
prises in its blindness to risks other than viral transmis-
sion that could be obviated through the provision of
sterile injecting paraphernalia. The reuse of stored filters
for injecting, for example, is likely to pose a bacterial
and fungal infection risk. Although bacterial risks from
using non-sterile and alternative water sources are not
well documented, our qualitative data in combination
with the high prevalence of SSTI and related hospitalisa-
tion among the survey sample indicate a need for policy
reform. We call for funding and increased supply of ad-
equate quantities of WFI to people who do not have ac-
cess to clean water. Greater awareness of the legality of
5 ml WFI provision for PWID is likely to facilitate distri-
bution, given that these are marketed at a similar cost to
2 ml glass ampoules. Our study finding dissemination
groups with PWID indicate that 5 ml WFI are desired,
but that some sharing would take place. Despite evi-
dence of reduced HCV transmission risk through water,
provision of small volume (2 ml) plastic ampoules (li-
censed but not currently marketed, and therefore costly)
would be ideal. Relaxation of prescription only medicine
regulations that prevent drug services and other non-
pharmacy suppliers splitting WFI packs (10 ampules)
into smaller units would remove an additional important
barrier to adequate distribution.
The use of unsafe alternatives to WFI potentiates high
health risks and health system burden among an increas-
ingly vulnerable population of unstably housed PWID.
We call, therefore, not only for policy reform but also
for a revolution in harm reduction messaging, whereby
“best practice” is presented as just one option among
many—with others offered tailored to different levels of
environmental constraint. In a context whereby PWID
report use of puddle water, alcohol and saliva to prepare
drugs for injection, harm reduction messaging that en-
joins people to “wash their hands” before injecting,
alongside the provision of injecting kits without water,
enacts a structural violence—shaming through a denial
of the constraints faced by the most marginalised. Here,
disconnect between drug treatment providers, policy
makers and those who they are served to care for is pro-
found. Messaging based on a hierarchy of safety provides
an alternative to the alienating potential of “hyper
sanitary” [57] best practice. In response to the findings
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of the Care & Prevent study, Exchange Supplies (a so-
cial enterprise in the UK that provides harm reduc-
tion equipment and materials) has adapted its water
risks poster for display in NSP (Fig. 1). In addition,
the wider environmental constraints placed on action-
ing such advice need to be considered. More wide-
spread distribution of WFI from NSP is required,
alongside the wider provision of methods to clean
hands and injecting sites. This is particularly crucial
given the recent COVID-19 pandemic and constraints
faced by the most marginalised to enacting protective
practices. Installation of public water fountains, along-
side the provision of handheld water purifiers and
similar devices to homeless people who inject drugs,
could also be considered as an environmentally sound
way to provide water for skin washing and injection
preparation practices.
In the time this paper has been in review, we have de-
veloped, in collaboration with Exchange Supplies, a
prototype street injecting kit (Fig. 2). This responds to
cost constraints to widespread WFI provision and the
need identified through our work specifically for people
who prepare and inject drugs in public spaces for access
to water. The kit comes in a box that doubles as a stable
safe injecting space with windbreak. Contents comprise
two 30G syringes, four swabs, two Sterifilts, two vitamin
C sachets, two spoons, two “fitstick” syringe disposal de-
vices, two antimicrobial handwipes in a sachet and two
5ml sterile water ampoules. The addition of antimicro-
bial handwipes attends to difficulties people have in
accessing running water for washing hands and is of
added value in relation to COVID-19 and other infection
prevention for PWID—many of whom have compro-
mised immune and respiratory systems.
Fig. 1 Water risks poster – Exchange Supplies (2019)
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Conclusion
Our study highlights the role of unsafe liquids used to
prepare drug injection solutions. Given the serious
health harms associated with this practice, it is crucial
that services engage with the everyday realities of people
living on the streets and amend service provision ac-
cordingly. Current harm reduction messaging and inject-
ing equipment provision in the UK is failing to meet the
needs of the most marginalised. There is an urgent need
to revisit the marketing and/or legal limits to the volume
of WFI ampoules supplied to PWID, particularly given
that concerns about sharing water increasing HCV
transmission seem not to have been borne out in subse-
quent analysis.
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